Background: There are scarce epidemiological data on cardiovascular risk profile of chronic hemodialysis patients in Brazil.
Objective: The CORDIAL study was designed to evaluate cardiovascular risk factors and follow up a hemodialysis population in a Brazilian metropolitan city.
Methods: All patients undergoing regular hemodialysis for chronic renal failure in all fifteen nephrology centers of Porto Alegre were considered for inclusion in the baseline phase of the CORDIAL study.
Introduction: The most common cause of chronic renal failure (CRF) among patients who are starting on dialysis in developed countries is diabetes mellitus (DM), with growing rates approaching 50%. In Brazil, the available data indicate a lower prevalence, around 27%, even though it is also increasing.
Objectives: To estimate the prevalence of DM in the adult population of patients on hemodialysis for CRF in Porto Alegre, Brazil.
Objective: To compare the management of patients with ischemic heart disease being followed up in a general cardiology outpatient clinic with that of patients being followed up in an outpatient clinic specific for ischemic heart disease, emphasizing the lipid profile and the pharmacological treatment prescribed.
Methods: Data were collected from the medical records of 52 patients consecutively treated in the outpatient clinic for ischemic heart disease (group I) and of 43 patients treated in the general cardiology outpatient clinic (group II), the anatomical diagnosis of ischemic heart disease being the basic condition for their inclusion in the study. The criteria for dyslipidemia were as follows: total cholesterol > or = 200 mg/dL or LDL-cholesterol > 100 mg/dL, or both, in patients using or not lipid-lowering drugs, and the use of lipid-lowering drugs, even when the total cholesterol or LDL-cholesterol levels were < 200 mg/dL and 100 mg/dL, respectively, or both.